Treatment for hypertension in Niger

Niger: Treatment for hypertension was 13.4% in 2019. ▲ Rising

Latest (2019)
13.4%
Change on year
up 6.3%
World rank
191st
of 192 countries
All-time high
13.4%
in 2019
All-time low
3.5%
in 1990
Years of data
30
1990–2019

Treatment for hypertension in Niger, 1990–2019

4681012141990200420191990: 3.5 % of adults ages 30-79 with hypertension1991: 3.6 % of adults ages 30-79 with hypertension1992: 3.6 % of adults ages 30-79 with hypertension1993: 3.7 % of adults ages 30-79 with hypertension1994: 3.8 % of adults ages 30-79 with hypertension1995: 3.9 % of adults ages 30-79 with hypertension1996: 4 % of adults ages 30-79 with hypertension1997: 4.1 % of adults ages 30-79 with hypertension1998: 4.2 % of adults ages 30-79 with hypertension1999: 4.4 % of adults ages 30-79 with hypertension2000: 4.6 % of adults ages 30-79 with hypertension2001: 4.8 % of adults ages 30-79 with hypertension2002: 5 % of adults ages 30-79 with hypertension2003: 5.3 % of adults ages 30-79 with hypertension2004: 5.6 % of adults ages 30-79 with hypertension2005: 5.9 % of adults ages 30-79 with hypertension2006: 6.2 % of adults ages 30-79 with hypertension2007: 6.6 % of adults ages 30-79 with hypertension2008: 7 % of adults ages 30-79 with hypertension2009: 7.4 % of adults ages 30-79 with hypertension2010: 7.9 % of adults ages 30-79 with hypertension2011: 8.4 % of adults ages 30-79 with hypertension2012: 8.9 % of adults ages 30-79 with hypertension2013: 9.4 % of adults ages 30-79 with hypertension2014: 10 % of adults ages 30-79 with hypertension2015: 10.6 % of adults ages 30-79 with hypertension2016: 11.3 % of adults ages 30-79 with hypertension2017: 11.9 % of adults ages 30-79 with hypertension2018: 12.6 % of adults ages 30-79 with hypertension2019: 13.4 % of adults ages 30-79 with hypertension

Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of adults ages 30-79 with hypertension.

Analysis

In 2019, treatment for hypertension in Niger stood at 13.4%. That is the highest value across all 30 years on record.

That represents a change of up 6.3% on the previous year and up 81.1% over ten years.

Over the whole period, treatment for hypertension in Niger peaked at 13.4% in 2019 and was at its lowest, 3.5%, in 1990.

Niger ranks 191st of 192 countries on this measure, in the bottom quarter.

The long-run direction has been consistently rising across the 30 years of available data.

Treatment for hypertension in Niger, year by year

Annual values for Treatment for hypertension (% of adults ages 30-79 with hypertension) in Niger, 1990 to 2019.
Year % of adults ages 30-79 with hypertension Change
1990 3.5%
1991 3.6% +2.9%
1992 3.6% +0.0%
1993 3.7% +2.8%
1994 3.8% +2.7%
1995 3.9% +2.6%
1996 4.0% +2.6%
1997 4.1% +2.5%
1998 4.2% +2.4%
1999 4.4% +4.8%
2000 4.6% +4.5%
2001 4.8% +4.3%
2002 5.0% +4.2%
2003 5.3% +6.0%
2004 5.6% +5.7%
2005 5.9% +5.4%
2006 6.2% +5.1%
2007 6.6% +6.5%
2008 7.0% +6.1%
2009 7.4% +5.7%
2010 7.9% +6.8%
2011 8.4% +6.3%
2012 8.9% +6.0%
2013 9.4% +5.6%
2014 10.0% +6.4%
2015 10.6% +6.0%
2016 11.3% +6.6%
2017 11.9% +5.3%
2018 12.6% +5.9%
2019 13.4% +6.3%

Niger compared with similar countries

  • Niger's 13.4% is below the median for low income countries, which is 24.5%, 55% of the median. (25 countries reporting)
  • Niger's 13.4% is below the median for Sub-Saharan Africa, which is 24.9%, 54% of the median. (48 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
1990s 3.9% 3.5% 4.4% 10
2000s 5.8% 4.6% 7.4% 10
2010s 10.4% 7.9% 13.4% 10

Countries ranked near Niger

  1. 189 Solomon Islands 14.5% compare
  2. 190 Vanuatu 13.6% compare
  3. 192 Rwanda 10.6% compare

See the full ranking of 235 places →

More health data for Niger

All data for Niger →

Frequently asked questions

What is treatment for hypertension in Niger?
Treatment for hypertension in Niger was 13.4% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
What is the highest treatment for hypertension recorded in Niger?
The highest recorded value was 13.4% in 2019.
What is the lowest treatment for hypertension recorded in Niger?
The lowest recorded value was 3.5% in 1990.
How does Niger rank for treatment for hypertension?
Niger ranks 191st out of 192 countries with data for 2019.
Is treatment for hypertension rising or falling in Niger?
Over the last ten years it is up 81.1%. The long-run trend across the full record is rising.
Where does this Niger data come from?
The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension (% of adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Treatment for hypertension in Niger. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 16 September 2026, from https://health.statizoid.com/stat/treatment-for-hypertension-percent-of-adults-ages-30-79-with-hypertension/niger/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-for-hypertension-percent-of-adults-ages-30-79-with-hypertension/niger/">Treatment for hypertension in Niger</a> — Statizoid

About this data

Indicator
Treatment for hypertension (% of adults ages 30-79 with hypertension)
Unit
% of adults ages 30-79 with hypertension
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.